This compound is a pharmaceutical intermediate used in the manufacturing process of ledipasvir, an active pharmaceutical ingredient. It features a complex bicyclic structure with a boronic ester group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1256387-87-7
Ledipasvir Intermediate
pharmaceutical intermediate
(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
pharmaceutical intermediate
(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid phenylmethyl ester
pharmaceutical intermediate
N-[(1S)-1-[[(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester
pharmaceutical intermediate
2-methyl-2-(4-vinylphenyl)propanoic acid
pharmaceutical intermediate
2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid
pharmaceutical intermediate
tert-butyl (1R,3S,4S)-3-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylate
MYPUONINDNZBTH-GMBSWORKSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC3=C(C=C2)N=C(N3)[C@@H]4[C@H]5CC[C@H](C5)N4C(=O)OC(C)(C)C
—